299 related articles for article (PubMed ID: 26439305)
21.
Martelli F; Verachi P; Zingariello M; Mazzarini M; Vannucchi AM; Lonetti A; Bacci B; Sarli G; Migliaccio AR
Front Genet; 2021; 12():720552. PubMed ID: 34707640
[TBL] [Abstract][Full Text] [Related]
22. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
[TBL] [Abstract][Full Text] [Related]
23. Captopril mitigates splenomegaly and myelofibrosis in the Gata1
Corey SJ; Jha J; McCart EA; Rittase WB; George J; Mattapallil JJ; Mehta H; Ognoon M; Bylicky MA; Summers TA; Day RM
J Cell Mol Med; 2018 Sep; 22(9):4274-4282. PubMed ID: 29971909
[TBL] [Abstract][Full Text] [Related]
24. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
[TBL] [Abstract][Full Text] [Related]
25. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
[TBL] [Abstract][Full Text] [Related]
26. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice).
Vannucchi AM; Bianchi L; Cellai C; Paoletti F; Rana RA; Lorenzini R; Migliaccio G; Migliaccio AR
Blood; 2002 Aug; 100(4):1123-32. PubMed ID: 12149188
[TBL] [Abstract][Full Text] [Related]
27. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
29. [Pathogenesis and Targeted Treatment Progress of Splenomegaly in Primary Myelofibrosis--Review].
Chen ZW; Wang SX; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):308-312. PubMed ID: 38387940
[TBL] [Abstract][Full Text] [Related]
30. Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation.
Zingariello M; Fabucci ME; Bosco D; Migliaccio AR; Martelli F; Rana RA; Zetterberg E
Biotech Histochem; 2010 Apr; 85(3):157-70. PubMed ID: 20426698
[TBL] [Abstract][Full Text] [Related]
31. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
Pizzi M; Gergis U; Chaviano F; Orazi A
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
[TBL] [Abstract][Full Text] [Related]
32. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
[TBL] [Abstract][Full Text] [Related]
33. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
[TBL] [Abstract][Full Text] [Related]
34. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.
Song MK; Park BB; Uhm JE
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562644
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
36. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.
Chagraoui H; Komura E; Tulliez M; Giraudier S; Vainchenker W; Wendling F
Blood; 2002 Nov; 100(10):3495-503. PubMed ID: 12393681
[TBL] [Abstract][Full Text] [Related]
37. Immunohistopathological Analysis of Extramedullary Hematopoiesis and Angiogenesis of Spleen in a Case of Primary Myelofibrosis with Huge Splenomegaly.
Kawano N; Saito N; Yoshida S; Kitanaka A; Shide K; Marutsuka K; Ohshima K; Shimoda K
Tohoku J Exp Med; 2022 Feb; 256(2):119-125. PubMed ID: 35173090
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
39. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
Wen QJ; Yang Q; Goldenson B; Malinge S; Lasho T; Schneider RK; Breyfogle LJ; Schultz R; Gilles L; Koppikar P; Abdel-Wahab O; Pardanani A; Stein B; Gurbuxani S; Mullally A; Levine RL; Tefferi A; Crispino JD
Nat Med; 2015 Dec; 21(12):1473-80. PubMed ID: 26569382
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
